These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37188567)

  • 1. Outcomes of Ventricular Tachycardia Catheter Ablation in Patients Who Underwent Cardiac Defibrillator Implantation Nationwide Readmission Database Analysis.
    Moustafa A; Elzanaty A; Karim S; Eltahawy E; Kahaly O; Elbatanony L; Khalil M; Maraey A; Chacko P
    Am J Cardiol; 2023 Jul; 198():108-112. PubMed ID: 37188567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.
    Yousuf OK; Zusterzeel R; Sanders W; Caños D; Dekmezian C; Silverman H; Calkins H; Berger R; Tandri H; Nazarian S; Strauss DG
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1189-1199. PubMed ID: 30236393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography.
    Field ME; Gold MR; Reynolds MR; Goldstein L; Lee SHY; Kalsekar I; Coplan P; Wong C; Khanna R; Winterfield JR
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):417-422. PubMed ID: 31868258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.
    Martinez BK; Baker WL; Konopka A; Giannelli D; Coleman CI; Kluger J; Cronin EM
    Heart Rhythm; 2020 Jan; 17(1):e206-e219. PubMed ID: 31082362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA.
    Mehta V; Boo LM; Ghaly N; Kalsekar I; Zhang S; Yadalam S; Khanna R; Rahman M
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32998979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term outcomes associated with inpatient ventricular tachycardia catheter ablation.
    Sharma P; Tripathi B; Naraparaju V; Patel M; Bhagat A; Yerasi C; Kumar V; Aujla P; Singh G; Lahewala S; Arora S; Deshmukh A; Tolat A
    Pacing Clin Electrophysiol; 2020 May; 43(5):444-455. PubMed ID: 32196697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
    Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
    Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.
    Lima da Silva G; Nunes-Ferreira A; Cortez-Dias N; de Sousa J; J Pinto F; Caldeira D
    J Interv Card Electrophysiol; 2020 Dec; 59(3):603-616. PubMed ID: 32948937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis.
    Delacrétaz E; Brenner R; Schaumann A; Eckardt L; Willems S; Pitschner HF; Kautzner J; Schumacher B; Hansen PS; Kuck KH;
    J Cardiovasc Electrophysiol; 2013 May; 24(5):525-9. PubMed ID: 23350967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.
    Liu G; Xu X; Yi Q; Lv T
    J Interv Card Electrophysiol; 2021 Sep; 61(3):435-443. PubMed ID: 33723693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.